119th Congress
H.R. 10369
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Ryan Mackenzie(R-PA)
- Introduced
- Sep 14, 2026
- Policy area
- Health
- Committees
- House Committee on Education and Workforce; House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (4)
Original cosponsors (4)
- Carol D. Miller (R-WV)
- Jake Auchincloss (D-MA)
- Lucy McBath (D-GA)
- Rick W. Allen (R-GA)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
Latest action(Sep 14, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Sep 14, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Sep 14, 2026
Introduced in House